Adaptive Biotechnologies (ADPT) Return on Equity (2019 - 2026)

Adaptive Biotechnologies (ADPT) has 8 years of Return on Equity data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Equity changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Equity climbed to 0.0% in Q1 2026 per ADPT's latest filing, from 0.0% in the prior quarter.
• The five-year high for Return on Equity was 0.0% in Q1 2026, with the low at 0.01% in Q3 2024.
• Average Return on Equity over 5 years is 0.01%, with a median of 0.0% recorded in 2023.
• The widest YoY moves for Return on Equity: up 0 bps in 2022, down 0 bps in 2022.
• Adaptive Biotechnologies' Return on Equity stood at 0.0% in 2022, then tumbled by 60 bps to 0.01% in 2023, then fell by 11 bps to 0.01% in 2024, then soared by 62 bps to 0.0% in 2025, then gained by 19 bps to 0.0% in 2026.
• Business Quant data shows ADPT's Return on Equity at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.